Skip to content

BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH

CIK 0001310488 · Laboratory Analytical Instruments · OTC

  • SILVER RIVER VENTURES, INC. (until 2006-02-24)
← back to feed
Revenue (TTM)
$23.29K
+9.0% YoY Q1 May 2026
Net Income (TTM)
−$1.28M
−163.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.03
−100.0% YoY Q1 May 2026
Gross Margin
25.6%
Q1 May 2026
Operating Margin
-2,122.2%
Q1 May 2026
Net Margin
-5,482.1%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$6.35K
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
33.55M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings